Stonehage Fleming Financial Services’s BioNTech BNTX Stock Holding History

Stonehage Fleming Financial Services’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.79K	Hold	30	–	–	﹤0.01%	207
2026 Q1	$2.67K	Hold	30	–	–	﹤0.01%	218
2025 Q4	$2.86K	Hold	30	–	–	﹤0.01%	215
2025 Q3	$2.96K	Hold	30	–	–	﹤0.01%	211
2025 Q2	$3.19K	Hold	30	–	–	﹤0.01%	204
2025 Q1	$2.73K	Hold	30	–	–	﹤0.01%	182
2024 Q4	$3.42K	Hold	30	–	–	﹤0.01%	212
2024 Q3	$3.56K	Hold	30	–	–	﹤0.01%	210
2024 Q2	$2.41K	Hold	30	–	–	﹤0.01%	219
2024 Q1	$3.74K	Hold	30	–	–	﹤0.01%	166
2023 Q4	$3.17K	Hold	30	–	–	﹤0.01%	220
2023 Q3	$3.26K	Hold	30	–	–	﹤0.01%	238
2023 Q2	$3.24K	Hold	30	–	–	﹤0.01%	191
2023 Q1	$3.74K	Hold	30	–	–	﹤0.01%	166
2022 Q4	$4.51K	Sell	30 -200	-87%	-$30.8K	﹤0.01%	164
2022 Q3	$31K	Buy	+230	New	+$35.2K	﹤0.01%	149
2021 Q1	–	Sell	-600	Closed	-$49K	–	188
2020 Q4	$49K	Buy	+600	New	+$58.9K	﹤0.01%	163

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Stonehage Fleming Financial Services's BNTX Position: Q2 2026 in Review

Stonehage Fleming Financial Services held its BioNTech (BNTX) position steady in Q2 2026 at 30 shares worth $2.79K. The position accounts for ﹤0.01% of the portfolio, ranked #207.

Stonehage Fleming Financial Services first reported a position in BNTX in Q4 2020 and has held it in 17 quarters since. The position peaked at $49K in Q4 2020. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Stonehage Fleming Financial Services held 30 shares of BioNTech worth $2.79K as of Q2 2026.
Stonehage Fleming Financial Services left its BioNTech share count unchanged in Q2 2026.
BioNTech made up ﹤0.01% of Stonehage Fleming Financial Services's portfolio in Q2 2026, its #207 holding.
Stonehage Fleming Financial Services first reported a position in BioNTech in Q4 2020 and has held it in 17 quarters since.
Stonehage Fleming Financial Services's BioNTech position peaked at $49K in Q4 2020.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2026, filed 17 Aug 2026.